Triple-negative breast cancer (TNBC) is a heterogeneous type of breast cancer that is characterized by the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2/neu (HER-2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.